Literature DB >> 20402759

Social consequences of multiple sclerosis: clinical and demographic predictors - a historical prospective cohort study.

C C H Pfleger1, E M Flachs, N Koch-Henriksen.   

Abstract

BACKGROUND: Time to disability pension is one of the endpoints to be used to determine the prognosis of multiple sclerosis (MS) in prospective studies.
OBJECTIVE: To assess the time to cessation of work and receiving disability pension in MS, and how it may depend on gender, type of work and age and symptom at onset.
METHOD: A total of 2240 Danes with onset of definite/probable MS 1980-1989, identified from the Danish MS-Registry, were included. Information on social endpoints was retrieved from Statistics Denmark. Cox regression analyses were used with onset as starting point.
RESULTS: Afferent onset symptoms [hazard ratio (HR 0.57)] and non-physical type of work (HR 0.70) were favourable prognostic factors compared with high age at onset, physical work and efferent symptoms at onset. The mean time to disability pension was 13 years for patients with afferent/brainstem onset symptom but 8.7 years for those with efferent onset symptoms (P < 0.0001). The effect of onset symptom was reduced and the effect of sex became significant when all covariates and age at onset were included in multivariate Cox regression.
CONCLUSIONS: Onset age, type of onset symptom and work are robust predictors of disability pension in MS. Disability pension proves to be a reliable milestone in estimation of the prognosis of MS.
© 2010 The Author(s). Journal compilation © 2010 EFNS.

Entities:  

Mesh:

Year:  2010        PMID: 20402759     DOI: 10.1111/j.1468-1331.2010.03020.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  8 in total

1.  Occupational outcomes of people with multiple sclerosis: a scoping review.

Authors:  Bruno Kusznir Vitturi; Alborz Rahmani; Guglielmo Dini; Alfredo Montecucco; Nicoletta Debarbieri; Elvira Sbragia; Paolo Bandiera; Michela Ponzio; Mario Alberto Battaglia; Tommaso Manacorda; Benedetta Persechino; Giuliana Buresti; Matilde Inglese; Paolo Durando
Journal:  BMJ Open       Date:  2022-07-01       Impact factor: 3.006

2.  Importance of early treatment decisions on future income of multiple sclerosis patients.

Authors:  Andrius Kavaliunas; Ali Manouchehrinia; Hanna Gyllensten; Kristina Alexanderson; Jan Hillert
Journal:  Mult Scler J Exp Transl Clin       Date:  2020-10-07

3.  Earnings and Financial Compensation from Social Security Systems Correlate Strongly with Disability for Multiple Sclerosis Patients.

Authors:  Andrius Kavaliunas; Michael Wiberg; Petter Tinghög; Anna Glaser; Hanna Gyllensten; Kristina Alexanderson; Jan Hillert
Journal:  PLoS One       Date:  2015-12-22       Impact factor: 3.240

4.  SOX2+ cell population from normal human brain white matter is able to generate mature oligodendrocytes.

Authors:  Jorge Oliver-De La Cruz; Josefa Carrión-Navarro; Noemí García-Romero; Antonio Gutiérrez-Martín; Elisa Lázaro-Ibáñez; Carmen Escobedo-Lucea; Rosario Perona; Cristobal Belda-Iniesta; Angel Ayuso-Sacido
Journal:  PLoS One       Date:  2014-06-05       Impact factor: 3.240

5.  Early Retirement: A Meta-Analysis of Its Antecedent and Subsequent Correlates.

Authors:  Gabriela Topa; Marco Depolo; Carlos-Maria Alcover
Journal:  Front Psychol       Date:  2018-01-04

6.  Cognitive function predicts work disability among multiple sclerosis patients.

Authors:  Andrius Kavaliunas; Petter Tinghög; Emilie Friberg; Tomas Olsson; Kristina Alexanderson; Jan Hillert; Virginija Danylaite Karrenbauer
Journal:  Mult Scler J Exp Transl Clin       Date:  2019-01-14

7.  Aging With Multiple Sclerosis: Age-Related Factors and Socioeconomic Risks.

Authors:  Malthe Faurschou Wandall-Holm; Mads Albrecht Andersen; Mathias Due Buron; Melinda Magyari
Journal:  Front Neurol       Date:  2022-03-11       Impact factor: 4.003

8.  Prevalence and factors leading to unemployment in MS (multiple sclerosis) patients undergoing immunomodulatory treatment in Poland.

Authors:  Dorota Koziarska; Joanna Król; Danuta Nocoń; Przemysław Kubaszewski; Teresa Rzepa; Przemysław Nowacki
Journal:  PLoS One       Date:  2018-04-10       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.